Synthesis and Evaluation of <sup>99m</sup>Tc-Tricabonyl Labeled Isonitrile Conjugates for Prostate-Specific Membrane Antigen (PSMA) Image

Synthesis and Evaluation of <sup>99m</sup>Tc-Tricabonyl Labeled Isonitrile Conjugates for Prostate-Specific Membrane Antigen (PSMA) Image

Prostate-specific membrane antigen (PSMA) is a biomarker expressed on the surface of prostate cancer (PCa). In an effort to improve the detection and treatment of PCa, small urea-based PSMA inhibitors have been studied extensively. In the present study, we aimed to develop <sup>99m</sup>...

Full description

Bibliographic Details
Main Authors:	Nadeem Ahmed Lodhi, Ji Yong Park, Kyuwan Kim, Mi Kyung Hong, Young Joo Kim, Yun-Sang Lee, Gi Jeong Cheon, Keon Wook Kang, Jae Min Jeong
Format:	Article
Language:	English
Published:	MDPI AG 2020-01-01
Series:	Inorganics
Subjects:	prostate cancer prostate-specific membrane antigen technetium-99m spect isonitrile
Online Access:	https://www.mdpi.com/2304-6740/8/1/5

Similar Items

Synthesis and Evaluation of Novel Norfloxacin Isonitrile <sup>99m</sup>Tc Complexes as Potential Bacterial Infection Imaging Agents
by: Si’an Fang, et al.
Published: (2021-04-01)

Preparation and Biological Evaluation of [<sup>99m</sup>Tc]Tc-CNGU as a PSMA-Targeted Radiotracer for the Imaging of Prostate Cancer
by: Di Xiao, et al.
Published: (2020-11-01)

A Review on the Current State and Future Perspectives of [<sup>99m</sup>Tc]Tc-Housed PSMA-i in Prostate Cancer
by: Sara Brunello, et al.
Published: (2022-04-01)

Preparation and Evaluation of Novel Folate Isonitrile <sup>99m</sup>Tc Complexes as Potential Tumor Imaging Agents to Target Folate Receptors
by: Junhong Feng, et al.
Published: (2021-07-01)

Synthesis and Evaluation of <sup>99m</sup>Tc-Labeled PSMA-Targeted Tracers Based on the Lys-Urea-Aad Pharmacophore for Detecting Prostate Cancer with Single Photon Emission Computed Tomography
by: Kelly Lu, et al.
Published: (2023-06-01)

Preclinical Evaluation of a Novel High-Affinity Radioligand [<sup>99m</sup>Tc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)
by: Ekaterina Bezverkhniaia, et al.
Published: (2023-12-01)

Preparation and Bioevaluation of a Novel <sup>99m</sup>Tc-Labeled Glucose Derivative Containing Cyclohexane as a Promising Tumor Imaging Agent
by: Junhong Feng, et al.
Published: (2023-04-01)

Synthesis and preclinical evaluation of novel 99mTc-labeled PSMA ligands for radioguided surgery of prostate cancer
by: Jan-Philip Kunert, et al.
Published: (2023-01-01)

Development of in-House Synthesis and Quality Control of [<sup>99m</sup>Tc]Tc-PSMA-I&S
by: Elisabeth Plhak, et al.
Published: (2023-01-01)

Technetium-99m-MIBI-SPECT for prostate cancer diagnosis
by: M. Kuru, et al.
Published: (2020-01-01)

Radiochemical and biological assessments of a PSMA-I&S cold kit for fast and inexpensive 99mTc-labeling for SPECT imaging and radioguided surgery in prostate cancer
by: Leonardo Lima Fuscaldi, et al.
Published: (2023-10-01)

Optimization of the Pharmacokinetic Profile of [<sup>99m</sup>Tc]Tc-N<sub>4</sub>-Bombesin Derivatives by Modification of the Pharmacophoric Gln-Trp Sequence
by: Thomas Günther, et al.
Published: (2022-09-01)

Diagnostic Performance of <sup>99m</sup>Tc-iPSMA SPECT/CT in the Initial Staging of Patients with Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer: A Comparative Analysis with <sup>18</sup>F-PSMA-1007 PET/CT
by: Joel E. Vargas-Ahumada, et al.
Published: (2023-12-01)

The GRPR Antagonist [<sup>99m</sup>Tc]Tc-maSSS-PEG<sub>2</sub>-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity
by: Ayman Abouzayed, et al.
Published: (2023-05-01)

Imaging Hydrogen Sulfide in Hypoxic Tissue with [<sup>99m</sup>Tc]Tc-Gluconate
by: Yongkyoung Kweon, et al.
Published: (2020-12-01)

Comparative Study of a Series of <sup>99m</sup>Tc(CO)<sub>3</sub> Mannosylated Dextran Derivatives for Sentinel Lymph Node Detection
by: Afroditi Papasavva, et al.
Published: (2021-08-01)

Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse
by: Heng-Chuan Su, et al.
Published: (2017-01-01)

[99cmTc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center
by: P. Werner, et al.
Published: (2020-05-01)

Current Status and Prospects of 99mTc-radiopharmaceuticals
by: TIAN Jiale;JIA Hongmei
Published: (2020-12-01)

Common Shortcomings in Study on Radiopharmaceutical Design Research: A Case Study of <sup>99m</sup>Tc-Labelled Methotrexate
by: Przemysław Koźmiński, et al.
Published: (2021-09-01)

Development of the <sup>99m</sup>Tc-Labelled SST<sub>2</sub> Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study
by: Doroteja Novak, et al.
Published: (2023-03-01)

<sup>99m</sup>Tc Labelling Strategies for the Development of Potential Nitroimidazolic Hypoxia Imaging Agents
by: Javier Giglio, et al.
Published: (2019-10-01)

Initial Experience of Clinical Use of [<sup>99m</sup>Tc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study
by: Jarosław B. Ćwikła, et al.
Published: (2021-10-01)

Physicochemical and Biological Study of <sup>99m</sup>Tc and <sup>68</sup>Ga Radiolabelled Ciprofloxacin and Evaluation of [<sup>99m</sup>Tc]Tc-CIP as Potential Diagnostic Radiopharmaceutical for Diabetic Foot Syndrome Imaging
by: Przemysław Koźmiński, et al.
Published: (2021-12-01)

<sup>99m</sup>Tc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe
by: Guillermina Ferro-Flores, et al.
Published: (2023-11-01)

Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m
by: Ekaterina Bezverkhniaia, et al.
Published: (2024-03-01)

Preparation and Clinical Translation Study of 99mTc-labeled Prostate-Specific Membrane Antigen Inhibitor HYNIC-P137
by: DUAN Xiaojiang;LIAO Xuhe;XIAO Di;ZHANG Zhuochen;ZHANG Junbo;FAN Yan;YANG Xing
Published: (2023-08-01)

[<sup>99m</sup>Tc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes
by: Berthold A. Nock, et al.
Published: (2021-10-01)

The efficacy of 99mTc-HYNIC-PSMA SPECT/CT in detecting primary lesions and metastasis in newly diagnosed prostate cancer
by: Taisong Wang, et al.
Published: (2023-06-01)

Cysteine Derivatized <sup>99m</sup>Tc-Labelled Fatty Acids as β-Oxidation Markers
by: Theodoros Tsotakos, et al.
Published: (2019-11-01)

Highly Efficient Micro-Scale Liquid-Liquid In-Flow Extraction of <sup>99m</sup>Tc from Molybdenum
by: Petra Martini, et al.
Published: (2021-09-01)

Diagnostic performance of 99mTc-HYNIC-PSMA SPECT/CT for biochemically recurrent prostate cancer after radical prostatectomy
by: Bo Li, et al.
Published: (2022-12-01)

Preparation and Bioevaluation of Novel <sup>99m</sup>Tc-Labeled Complexes with a 2-Nitroimidazole HYNIC Derivative for Imaging Tumor Hypoxia
by: Qing Ruan, et al.
Published: (2021-02-01)

Introduction of Re(CO)<sub>3</sub><sup>+</sup>/<sup>99m</sup>Tc(CO)<sub>3</sub><sup>+</sup> Organometallic Species into Vinylpyrrolidone-Allyliminodiacetate Copolymers
by: Nikolay Ivanovich Gorshkov, et al.
Published: (2021-06-01)

Preclinical Evaluation of <sup>99m</sup>Tc-Labeled GRPR Antagonists maSSS/SES-PEG<sub>2</sub>-RM26 for Imaging of Prostate Cancer
by: Ayman Abouzayed, et al.
Published: (2021-01-01)

14 MeV Neutrons for 99Mo/99mTc Production: Experiments, Simulations and Perspectives
by: Marco Capogni, et al.
Published: (2018-07-01)

Technetium-99m in production and use
by: Vučina Jurij, et al.
Published: (2009-01-01)

Study of gels of molybdenum with cerium in the preparation of generators of 99Mo - 99mTc
by: Vanessa Moraes, et al.
Published: (2005-10-01)

Radiolabeling of Platelets with <sup>99m</sup>Tc-HYNIC-Duramycin for In Vivo Imaging Studies
by: Keresztély Merkel, et al.
Published: (2023-12-01)

Comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer: a protocol for systematic review and meta-analysis
by: Garba Haruna Yunusa, et al.
Published: (2021-07-01)